Add to watchlist
€1.57
Last updated:06/10/2021
0K9A: F
FSD Pharma Inc

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and… Show more

P/E ratio
-

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
-3.524515M
-22.710624M
-544.36%
-39.12952M
-72.30%
-31.799793M
+18.73%
Cashflow
Sum up money going in and out company
-149.865K
-18.489905M
-12237.71%
-13.712725M
+25.84%
-19.130473M
-39.51%
Total liabilities
All combined debts and obligations
1.265995M
1.743806M
+37.74%
9.225376M
+429.04%
5.658622M
-38.66%
Company profile
CEO
Mr. Zeeshan Saeed
Market capitalization
Micro (57.08M)